Morphology and release kinetics of technetium-99m(V) dimercaptosuccinic acid loaded, poly(lactic-co-glycolic) acid microspehric delivery system. An experimental approach that may be used for targeted radiation treatment

Hellenic Journal of Nuclear Medicine

Volumn 10, Issue 1, 2007, Pages 9-13

  Shukla, Jaya ^a   Bandopadhyaya, Guru Pad ^a   Varma, Indira Kumari ^b   Kumar, Rakesh ^a   Maulik, Subir Kumar ^c  

^a Institute of Information Technology   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Double emulsion; Encapsulation of DMSA; Microspheres prepared with PVA; Surfactant concentrations

Indexed keywords

COPOLYMER; MACROGOL; MICROSPHERE; POLYGLACTIN; POLYVINYL ALCOHOL; RHENIUM 188; SUCCIMER TC 99M; SURFACTANT;

ARTICLE; CONCENTRATION RESPONSE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STRUCTURE; ENCAPSULATION; EVAPORATION; IN VITRO STUDY; ISOTOPE LABELING; RADIATION DOSE; RADIATION HAZARD; RISK REDUCTION; TEMPERATURE SENSITIVITY; THERMOGRAVIMETRY; TUMOR LOCALIZATION;

CAPSULES; DIFFUSION; DRUG COMPOUNDING; FEASIBILITY STUDIES; KINETICS; LACTIC ACID; MATERIALS TESTING; MICROSPHERES; POLYGLYCOLIC ACID; POLYMERS; RADIOPHARMACEUTICALS; RADIOTHERAPY; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID;

EID: 34247887459     PISSN: 11081430     EISSN: 17905427     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bimbaum DT, Kosmala JD, Henthorn DB, Brannon-Peppas L. Controlled release of β-estradiol from PLGA microparticles: the effect of organic phase solvent on encapsulation and release. J Controlled Release 2000; 65: 375-387.
2. Couvreur P, Blanco-Prieto MJ, Puisieux F, et al. Multiple emulsion technology for the design of microspheres containing peptides and oligopeptides. Adv Drug Deliv Rev 1997; 28: 85-96.
3. Edulund U, Albertsson AC. Advances in Polymer Science, Degradable Aliphatic Polyester, Ed. A.C Alberton, Springer. 2002, 157: 68.
4. 90Y-microspheres novel agents for targeted intracavitary radiotherapy. J Biomed Mater Res 1999, 28: 901-908.
5. Kronenthal RL. Biodegradable polymers in medicine and surgery. In: Kronenthal RL, Oser Z, Martin E. (eds), Polymers in Medicine and Surgery. Plenum Press: New York; 1975. p 119.
6. Lewis DH, Controlled release of bioactive agents from lactide/ glycolide polymers. In: Chasin M, Langer R. (eds), Biodegradable polymers as drug delivery systems. Marcel Dekker: New York; 1990. Chap 1, p 1.
7. Ertl B, Plazer P, Wirth M, Gabor F. Poly (D, L-lactic-co-glycolic acid) microspheres for sustained delivery and stabilization of camptothecin. J Controlled Release 1999; 61: 305-317.
8. Mu L, Feng SS. Fabrication, characterisation and in vitro release of paclitaxel (Taxol) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers. J Controlled Release 2001; 76: 239-254.
9. Edulund U, Albatsson, AC. Advances in Polymer Science, Degradable Aliphatic polyester, Ed. AC., Alberton, Springer 2002; 157 and 168.
10. 99mTc(V) DMSA uptake is mediated by NaPi cotransporter type III in tumour cell lines. Eur J Nucl Med Mol Imaging 2004; 31: 77-84.
11. Deutsch E, Libson K, Vanderheyden JL, et al. The chemistry of rhenium and Technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine. Nucl Med Biol 1986; 13: 465-477.
12. Ohta H, Yamamoto K, Endo K, et al. A new imaging agent for medullary carcinoma of the thyroid. J Nucl Med 1984; 25: 323-325.
13. Ohta H, Endo K, Fujita T, et al. Imaging of soft tissue. Tumours with Tc(V)-99m dimercaptosuccinic acid. A new tumour-seeking agent. Clin Nucl Med 1984; 9: 568-573.
14. 99mTc(V) DMSA: A new tumour-seeking agent. Nucl Med Commun 1988; 9: 105.
15. Davison A, Orvig C, Trop H, et al. Preparation of oxobis (dithiolato) complex of technetium(V) and rhenium(V). Inorg Chem 1980; 19: 1988-1992.
16. Blower PJ, Singh J, Clarke SEM. The chemical identity of pentavalent technetium-99m-dimercaptosuccinic acid. J Nucl Med 1991; 32: 845-849.
17. 188Re(V)DMSA distribution in patients with prostate cancer metastatic to bone. Eur J Nucl Med 2000; 27: 1405-1409.
18. 188Rhenium(V)dimercaptosuccinic acid loaded poly (lactic-co-glycolic) acid microspheres for targeted radiotherapy: Production and effectivity. Pharmazie 2005; 60: 583-587.
19. Saha GB (Ed) Fundamentals of Nuclear Pharmacy, Springer Verlag: New York; 1992. p 150.
20. Chen YH, Illum L, Davis SS. A Poly (D, L-lactide-co-glycolide) microspheres depot system for delivery of haloperidol. J Controlled Rel 1998; 55: 203-212.
21. Babay D, Hoffman A, Benita S. Design and release kinetics pattern evaluation of indomethacin microspheres intended for oral administration. Biomaterials 1988; 9: 482-488.
22. Park, K. Controlled Drug Delivery: Challenges and strategies, American Chemical Society, Washington DC; 1997. p 529-557.
23. Arshady R. Microspheres and microcapsules, a survey of manufacturing techniques: part III: Solvent evaporation. Polym Engin Sci 1990; 30: 915-924.
24. Jameela SR, Suma N, Jayakrishnan A. Protein release from poly (ε-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: A comparative study. Biomater Sci Polym Edn 1997; 8, 457-466.
25. Maeda H, Wu J, Sawa T, et al. Tumour vascular permeability and the EPR effect in macromolecular therapeutics: A review. J Controlled Rel 2000, 65: 271-284.